Literature DB >> 18058466

Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy.

P E Sijens1, M A A M Heesters, R H Enting, W T A van der Graaf, J H Potze, R Irwan, L C Meiners, M Oudkerk.   

Abstract

Diffusion tensor imaging and multiple voxel magnetic resonance spectroscopy were performed in the MRI follow-up of a patient with a glioma treated with temozolomide chemotherapy. Tumor shrinkage was paralleled by reductions in choline level and by increases in apparent diffusion coefficient indicating decreased cellularity. Within the tumor, choline level and apparent diffusion coefficient showed a significant inverse correlation (P < 0.01). Fractional anisotropy distribution in the tumor correlated positively with N-acetyl aspartate level (P < 0.001), indicating that these parameters reflect (remaining) axonal structure. Tumor lactate level, also found to decrease under therapy, did not correlate with any other parameter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058466     DOI: 10.1080/07357900701564028

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

Review 1.  Current concepts in the evaluation and management of WHO grade II gliomas.

Authors:  Joseph M Piepmeier
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

2.  Diffusion tensor MR imaging of cerebral gliomas: evaluating fractional anisotropy characteristics.

Authors:  M L White; Y Zhang; F Yu; S A Jaffar Kazmi
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

3.  Diffusion tensor tractography of the arcuate fasciculus in patients with brain tumors: Comparison between deterministic and probabilistic models.

Authors:  Zhixi Li; Kyung K Peck; Nicole P Brennan; Mehrnaz Jenabi; Meier Hsu; Zhigang Zhang; Andrei I Holodny; Robert J Young
Journal:  J Biomed Sci Eng       Date:  2013-02

4.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

Authors:  Anwar R Padhani; Guoying Liu; Dow Mu Koh; Thomas L Chenevert; Harriet C Thoeny; Taro Takahara; Andrew Dzik-Jurasz; Brian D Ross; Marc Van Cauteren; David Collins; Dima A Hammoud; Gordon J S Rustin; Bachir Taouli; Peter L Choyke
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.